Watch the BRIT Registry webinars to learn more about the findings from our first report, plans for the registry’s Phase 2, the benefits of IQAS, and much more.
Introduction
Dr Rubaiyat Haque
Headlines from the first BRIT registry report
Dr Mich Lajeunesse, Chair BRIT Steering Group
Access to immunotherapy services – equality and diversity
Prof MT Krishna, Chair RCP – IQAS scheme and BSACI EDI committee chair
Patient perspective on allergen immunotherapy
Amena Warner, Allergy UK
Setting up an immunotherapy service
Dr Jenny Rowley – Basingstoke
Final questions and Close
Headlines from Phase 2 Developments of the Registry
Dr Mich Lajeunesse, Chair BRIT Steering Group
IQAS Accreditation of Allergy Centres
Dr Nasreen Khan, IQAS Clinical Lead
Use of Component Resolved Diagnostics to Guide Allergen Immunotherapy
Prof Alex Santos, Clinical Professor of Paediatric Food Allergy
Palforzia Peanut OIT, a NICE Approved Treatment
Dr Louise Michaelis, Consultant Paediatrician specialising in childhood allergy
Final questions and Close